Abstract:1026 Objectives: At present, triple-negative breast cancer (TNBC) has no specific molecular target. Cell-derived nanoparticles have been gaining increasingly attention due to their ability to mimic the properties of their source cells. Herein, we design a new platform of cancer cell membrane-coated up-conversion nanoparticles (CCm-UCNP) for homologous-targeting multi-modal imaging, including up-conversion luminescence imaging (UCL), magnetic resonance imaging (MRI) and positron emission tomography (PET) tumor imaging, for specific diagnosis and differential diagnosis of TNBC. Methods: Differential centrifugation was used to gain pure cancer cell membranes of MDA-MB-231 cells (CCm231), and coating up-conversion nanoparticles (UCNPs) by physical extrusion through a 400 nm porous polycarbonate membrane. The characterization was measured, and the protein expression before and after cancer cell membrane-coated was confirmed. Inserting 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(polyethylene glycol)2000-Cy5 (DSPE-PEG-Cy5) into CCm231 to label nanoparticles, and homologous-targeting ability and immune evasion ability were observed through incubating Cy5-DSPE-PEG-CCm231-UCNPs with different kinds of breast cancer cells and Raw264.7 cells (a kind of mice macrophage) by confocal laser scanning microscope. CCK-8 assay was used to evaluate the cytotoxicity. CCm231-UCNPs and UCNPs were injected intravenously into MDA-MB-231 and MCF-7 tumor bearing mice for UCL and MRI respectively. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[azido(polyethylene glycol)-2000] (DSPE-PEG-N3) was inserted into CCm231to react with DBCO by click chemistry for radiolabeling 18F used for PET imaging. N3-DSPE-PEG-CCm231-UCNPs were injected intravenously into MDA-MB-231 and MCF-7 tumor bearing mice of 24 h pre-positioning respectively, then DBCO-L-NETA-Al18F were injected, followed by serial PET imaging and ex vivo biodistribution study. For evaluating systematic toxicity, BALB/c-nu mice (n = 6) received injection of the same concentration of CCm231-UCNPs, UCNPs and CCm231, PBS were used as control. Results: Core-shell structure of CCm231-UCNPs of ~ 25 nm in size, with the similar protein profile before and after membrane-coated were successfully synthesized. The fluorescence signal of MDA-MB-231 group was extremely higher than those of other cell groups. Raw264.7 had nearly no uptake of Cy5-DSPE-PEG-CCm231-UCNPs, which exhibited immune evasion ability. No obvious cytotoxicity of CCm231-UCNPs had been observed. In the image of UCL and MRI, CCm231-UCNPs to MDA-MB-231 tumor group showed highest tumor site uptake, and the best imaging time was 24 h post-injection. Lower fluorescence signal of liver was observed compared to the group of UCNPs. As for PET imaging, N3-DSPE-PEG-CCm231-UCNPs to MDA-MB-231 tumor group showed highest tumor site uptake (6.39±1.12, 4.97±0.52, 4.70±0.9 and 4.05±0.5 %ID/g at 0.5, 1, 2 and 4h respectively) compared with those in MCF-7 tumor group (1.48±0.18, 1.16±0.10, 1.28±0.09 and 1.20±0.14 %ID/g at 0.5, 1, 2 and 4h respectively). Also, the liver and spleen were not visible. Neither death nor significant difference in body weight among four groups were observed after 30 days. Blood routine, hepatic and renal functions tests, and histology analysis suggested good biocompatibility of CCm231-UCNPs in vivo. Conclusions: We have successfully constructed CCm231-UCNPs, and the immune evasion ability and homologous targeting ability were confirmed by in vitro experiments and in vivo multi-modal imaging, including UCL, MRI and PET. No significant cytotoxicity and biological toxicity of these biomimetic nanoparticles were detected. Our study provides a new method for specific diagnosis and differential diagnosis of TNBC. Funding: This work was supported by the National Natural Science Foundation of China (No. 81630049, 81801738 and 81501532).

3D culture boosting fullerenol nanoparticles to induce calreticulin exposure on MCF-7 cells for enhanced macrophage-mediated cell removal

Fullerenols boosting the therapeutic effect of anti-CD47 antibody to trigger robust anti-tumor immunity by inducing calreticulin exposure

NIR-II Light-driven genetically edited nanoparticles with inherent CRT-inducing capability for macrophage-mediated immunotherapy

FNIII14 Peptide-Enriched Membrane Nanocarrier to Disrupt Stromal Barriers through Reversing CAFs for Augmenting Drug Penetration in Tumors

Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy

Stromal Barrier-Dismantled Nanodrill-Like and Cancer Cell-Targeted Ph-Responsive Polymeric Micelles for Further Enhancing the Anticancer Efficacy of Doxorubicin

Macrophage-Mimic Hollow Mesoporous Fe-Based Nanocatalysts for Self-Amplified Chemodynamic Therapy and Metastasis Inhibition via Tumor Microenvironment Remodeling

Furin-instructed Aggregated Gold Nanoparticles for Re-Educating Tumor Associated Macrophages and Overcoming Breast Cancer Chemoresistance.

Cancer cell membrane-coated up-conversion nanoparticles for homologous-targeting multimodality imaging

Anti-tumor Macrophages Activated by Ferumoxytol Combined or Surface-Functionalized with the TLR3 Agonist Poly (I : C) Promote Melanoma Regression.

Nanoparticle‐Enabled Dual Modulation of Phagocytic Signals to Improve Macrophage‐Mediated Cancer Immunotherapy

Cancer-associated Fibroblast-Targeted Nanodrugs Reshape Colorectal Tumor Microenvironments to Suppress Tumor Proliferation, Metastasis and Improve Drug Penetration

FAP‐Targeted Photodynamic Therapy Mediated by Ferritin Nanoparticles Elicits an Immune Response against Cancer Cells and Cancer Associated Fibroblasts

Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy

Macrophage-evading and tumor-specific apoptosis inducing nanoparticles for targeted cancer therapy

Effective Cancer Targeting and Imaging Using Macrophage Membrane-Camouflaged Upconversion Nanoparticles.

F3‐functionalized Nanoscale Metal–organic Frameworks for Tumor‐targeting Combined Chemotherapy and Chemodynamic Therapy

Ferrocene Functionalized Upconversion Nanoparticle Nanosystem with Efficient Near-Infrared-Light-Promoted Fenton-Like Reaction for Tumor Growth Suppression

Curcumin nanoparticles combined with 3D printed bionic tumor models for breast cancer treatment

Enhancement of Cancer Immunotherapy Using CRT Valgus Tumor Cell Membranes Coated Bacterial Whole Peptidoglycan Combined with Radiotherapy.

Cell Membrane-Camouflaged DOX-loaded Β-Glucan Nanoparticles for Highly Efficient Cancer Immunochemotherapy.